Cresset publishes April 2017 newsletter
The latest computational chemistry news from Cresset.
Cresset publishes March 2017 newsletter
The latest computational chemistry news from Cresset.
Cresset signs strategic alliance agreement to speed up drug design
A British-Chinese three-way agreement brings together expertise and innovation in the development of technologies for computational molecule design.
Cresset publishes January 2017 newsletter
The latest computational chemistry news from Cresset.
Cresset corporate rebrand reflects new structure for growing company
Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce a corporate rebrand, reflecting a new structure for this growing business.
Cresset publishes November & December 2016 newsletter
Computational chemistry news including CEO end of year message.
Cresset CEO chairs and presents at International Congress of Medichem, China
Cresset, innovative provider of software and contract services for small molecule discovery and design, is pleased to announce that this week, Dr Robert Scoffin, CEO, will chair the‘Sym 203: Pioneering Screening Technologies for Lead Compounds’ session at the Annual Congress of Medichem in Nanjing, China.
Cresset publishes October 2016 newsletter
Read the latest computational chemistry news from Cresset in its October newsletter.
What’s in the Cresset Discovery Services virtual screening toolbox?
Find out in Cresset's computational chemistry newsletter
Cresset publishes August 2016 newsletter
News from Cresset on software and contract research services for the discovery and design of novel compounds.
BASF Crop Protection chooses Cresset software for small molecule discovery and design
BASF Crop Protection has invested in a global licence from Cresset, giving their agrochemical researchers in Germany and India access to computational chemistry tools.
Cresset publishes June 2016 newsletter
News from Cresset on software and contract research services for the discovery and design of novel compounds.
Cresset to distribute BioMolTech protein preparation and docking software worldwide
Cresset announces partnership with BioMolTech for the exclusive global distribution and support of BioMolTech’s Lead Finder docking software.
Synergy between technologies speeds up drug optimisation cycle
Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce the release of the new Spark reagent databases based on available compounds from eMolecules. This will enable researchers to use Spark to find the best R-groups for their projects, while also enabling a close link between Spark’s suggestions and the chemistry…
SAI Life Sciences Limited, India, licenses Cresset molecular design tools
Cresset, an innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that SAI Life Sciences, a CDMO service provider with headquarters in Hyderabad India, has licensed several Cresset molecular design tools to advance their customer projects.
Dr Robert Scoffin, CEO of Cresset, awarded Fellowship of Royal Society of Chemistry
Cresset, innovative provider of software and discovery services for small molecule discovery and design, is pleased to announce that Cresset’s CEO, Dr Robert Scoffin, has been awarded a Fellowship of the Royal Society of Chemistry.
Re-Pharm compound with ‘steroid-sparing properties’ granted second patent
Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling, is pleased to announce a second UK patent on the re-purposed compound RP0217 for the treatment of ophthalmic indications.
Cresset Discovery Services provides drug design to Medicines for Malaria Venture
Cresset Discovery Services. provider of contract research services for early phase discovery, and Medicines for Malaria Venture (MMV) enter into a collaborative agreement to use computer-aided drug discovery to identify back-up compounds for a recently discovered molecule in MMV’s portfolio.
Domainex and Cresset announce drug discovery services alliance
Domainex and Cresset alliance will provide customers with world-class laboratory-based and computational drug discovery services through a seamless combination of their respective capabilities in chemistry and biology.
November and December news from Cresset
2015 review and computational chemistry news from Cresset.
Re-Pharm awarded patent for repurposed compound for treatment of inflammatory disorders
Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling, is pleased to announce that they have been awarded a GB patent on the re-purposed compound RP0217 for the treatment of inflammatory disorders.
Cancer Therapeutics Cooperative Research Centre chooses Blaze for virtual screening
Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that Cancer Therapeutics CRC (CTx), a collaborative partnership of leading research institutes, universities and biotechnology companies in Australia, has licensed its virtual screening software Blaze for cancer research.